Leaflet TROBALT 50mg / 100mg film-coated tablets
Indicated for: epilepsy
Route of administration: oral
Substance: retigabine (antiepileptic)
ATC: N03AX21 (Nervous system | Antiepileptics | Other antiepileptics)
This medicine may affect your ability to drive or use machines.
Dose adjustment may be needed in liver disease.
Dose adjustment may be needed in kidney disease.
This medicine may cause dizziness or vertigo.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Seek medical help if suicidal thoughts or major behavior changes occur.
This medicine may cause drowsiness or reduced alertness.
Retigabine is a medication used as an adjunctive treatment for partial epileptic seizures in adult patients. It works by activating potassium channels in the brain, reducing neuronal excitability and thereby preventing seizures.
The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important not to abruptly stop the treatment, as this may worsen seizures.
Side effects may include drowsiness, dizziness, blurred vision, or difficulty concentrating. In rare cases, severe adverse effects such as changes in skin or eye color may occur, requiring immediate medical attention.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as kidney or liver diseases, to ensure the safe use of retigabine.
General data about TROBALT 50mg / 100mg
- Substance: retigabine
- Date of latest medicines list: 01-07-2015
- Product code: W57384001
- Concentration: 50mg / 100mg
- Pharmaceutical form: film-coated tablets
- Quantity: 63
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for retigabine
- 100mg
- 200mg
- 300mg
- 400mg
- 50mg
- 50mg/100mg